NovoCure Ltd
NVCR- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001645113
No open-market purchases or sales by NovoCure Ltd insiders were filed in the last 90 days; 218 institutions reported holding it in 13F filings for Q2 2026, worth $1.57B in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in NovoCure Ltd as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 329
- No complete 13F data for Q4 2020
- Shares held
- 75.3M
- No complete 13F data for Q4 2020
- Total value
- $9.95B
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting NVCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $1.57B |
| Q1 2026 | 224 | $1.08B |
| Q4 2025 | 239 | $1.24B |
| Q3 2025 | 245 | $1.19B |
| Q2 2025 | 243 | $1.68B |
| Q1 2025 | 228 | $1.70B |
| Q4 2024 | 239 | $2.73B |
| Q3 2024 | 225 | $1.45B |
| Q2 2024 | 237 | $1.59B |
| Q1 2024 | 238 | $1.39B |
| Q4 2023 | 220 | $1.35B |
| Q3 2023 | 229 | $1.49B |
| Q2 2023 | 269 | $3.78B |
| Q1 2023 | 298 | $5.38B |
| Q4 2022 | 306 | $6.22B |
| Q3 2022 | 305 | $6.34B |
| Q2 2022 | 318 | $5.65B |
| Q1 2022 | 309 | $6.80B |
| Q4 2021 | 313 | $5.94B |
| Q3 2021 | 321 | $9.02B |
| Q2 2021 | 365 | $17.2B |
| Q1 2021 | 329 | $9.95B |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding NovoCure Ltd.
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Swiss National Bank | 332,800 | $44.0M | 0.03% | – | – |
| Invus Financial Advisors, LLC | 350,884 | $46.4M | 10.63% | – | – |
| Bank of New York Mellon Corp | 362,253 | $47.9M | 0.01% | – | – |
| Fiera Capital Corp | 377,358 | $49.9M | 0.14% | – | – |
| Two Sigma Investments, LP | 378,143 | $50.0M | 0.15% | – | – |
| Renaissance Technologies LLC | 408,575 | $54.0M | 0.07% | – | – |
| Two Sigma Advisers, LP | 451,900 | $59.7M | 0.16% | – | – |
| Nuveen Asset Management, LLC | 470,788 | $62.2M | 0.02% | – | – |
| Darsana Capital Partners LP | 500,000 | $66.1M | 1.85% | – | – |
| Voya Investment Management LLC | 510,156 | $67.4M | 0.14% | – | – |
| Legal & General Group Plc | 519,637 | $68.7M | 0.03% | – | – |
| Victory Capital Management Inc | 534,062 | $70.6M | 0.07% | – | – |
| Mitsubishi UFJ Trust & Banking Corp | 560,015 | $74.0M | 0.16% | – | – |
| Northern Trust Corp | 565,280 | $74.7M | 0.01% | – | – |
| Charles Schwab Investment Management Inc | 622,499 | $82.3M | 0.03% | – | – |
| Macquarie Group Ltd | 703,334 | $93.0M | 0.13% | – | – |
| Norges Bank | 812,134 | $107.3M | 0.02% | – | – |
| Wells Fargo & Company | 995,641 | $131.6M | 0.03% | – | – |
| Geode Capital Management, LLC | 1,217,314 | $160.7M | 0.02% | – | – |
| Price T Rowe Associates Inc | 1,227,702 | $162.3M | 0.02% | – | – |
| Morgan Stanley | 1,234,928 | $163.2M | 0.02% | – | – |
| Credit Suisse AG | 1,632,851 | $215.8M | 0.16% | – | – |
| State Street Corp | 2,047,896 | $270.7M | 0.02% | – | – |
| BlackRock Inc. | 6,424,960 | $849.3M | 0.03% | – | – |
| Vanguard Group Inc | 8,396,783 | $1.11B | 0.03% | – | – |
| Capital World Investors | 8,637,523 | $1.14B | 0.21% | – | – |
| Baillie Gifford & Co | 8,863,932 | $1.17B | 0.66% | – | – |
| FMR LLC | 9,088,439 | $1.20B | 0.10% | – | – |
| Capital International Investors | 9,117,624 | $1.21B | 0.30% | – | – |